For research use only. Not for therapeutic Use.
Licaminlimab (OCS-02) is a single-chain anti-TNF alpha antibody fragment. TNF alpha is an inflammatory cytokine produced by macrophages and monocytes during inflammation[1].
| Catalog Number | I042045 |
| Purity | ≥95% |
| Reference | [1]. Shettle L, et al. Topical Anti-TNFα Agent Licaminlimab (OCS-02) Relieves Persistent Ocular Discomfort in Severe Dry Eye Disease: A Randomized Phase II Study. Clin Ophthalmol. 2022 Jul 6;16:2167-2177. |
